Literature DB >> 24314137

Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif.

James I Fells1, Sue Chin Lee, Derek D Norman, Ryoko Tsukahara, Jason R Kirby, Sandra Nelson, William Seibel, Ruben Papoian, Renukadevi Patil, Duane D Miller, Abby L Parrill, Truc-Chi Pham, Daniel L Baker, Robert Bittman, Gabor Tigyi.   

Abstract

Modulation of autotaxin (ATX), the lysophospholipase D enzyme that produces lysophosphatidic acid, with small-molecule inhibitors is a promising strategy for blocking the ATX-lysophosphatidic acid signaling axis. Although discovery campaigns have been successful in identifying ATX inhibitors, many of the reported inhibitors target the catalytic cleft of ATX. A recent study provided evidence for an additional inhibitory surface in the hydrophobic binding pocket of ATX, confirming prior studies that relied on enzyme kinetics and differential inhibition of substrates varying in size. Multiple hits from previous high-throughput screening for ATX inhibitors were obtained with aromatic sulfonamide derivatives interacting with the hydrophobic pocket. Here, we describe the development of a ligand-based strategy and its application in virtual screening, which yielded novel high-potency inhibitors that target the hydrophobic pocket of ATX. Characterization of the structure-activity relationship of these new inhibitors forms the foundation of a new pharmacophore model of the hydrophobic pocket of ATX.
© 2013 FEBS.

Entities:  

Keywords:  autotaxin; enzymology; inhibitors; virtual screening

Mesh:

Substances:

Year:  2014        PMID: 24314137      PMCID: PMC4048651          DOI: 10.1111/febs.12674

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  23 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

3.  Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.

Authors:  E Jeffrey North; Angela L Howard; Irene W Wanjala; Truc Chi T Pham; Daniel L Baker; Abby L Parrill
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

4.  A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.

Authors:  James Gierse; Atli Thorarensen; Konstantine Beltey; Erica Bradshaw-Pierce; Luz Cortes-Burgos; Troii Hall; Amy Johnston; Michael Murphy; Olga Nemirovskiy; Shinji Ogawa; Lyle Pegg; Matthew Pelc; Michael Prinsen; Mark Schnute; Jay Wendling; Steve Wene; Robin Weinberg; Arthur Wittwer; Ben Zweifel; Jaime Masferrer
Journal:  J Pharmacol Exp Ther       Date:  2010-04-14       Impact factor: 4.030

Review 5.  Biological roles of lysophosphatidic acid signaling through its production by autotaxin.

Authors:  Shinichi Okudaira; Hiroshi Yukiura; Junken Aoki
Journal:  Biochimie       Date:  2010-04-22       Impact factor: 4.079

6.  Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe.

Authors:  Mitsuyasu Kawaguchi; Takayoshi Okabe; Shinichi Okudaira; Hiroshi Nishimasu; Ryuichiro Ishitani; Hirotatsu Kojima; Osamu Nureki; Junken Aoki; Tetsuo Nagano
Journal:  ACS Chem Biol       Date:  2013-06-03       Impact factor: 5.100

7.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

Review 8.  ATX-LPA receptor axis in inflammation and cancer.

Authors:  Shuying Liu; Mandi Murph; Nattapon Panupinthu; Gordon B Mills
Journal:  Cell Cycle       Date:  2009-11-27       Impact factor: 4.534

9.  Optimization of a pipemidic acid autotaxin inhibitor.

Authors:  Adrienne B Hoeglund; Heidi E Bostic; Angela L Howard; Irene W Wanjala; Michael D Best; Daniel L Baker; Abby L Parrill
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

10.  S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool.

Authors:  Gilles Ferry; Natacha Moulharat; Jean-Philippe Pradère; Patrice Desos; Anne Try; Annie Genton; Adeline Giganti; Monique Beucher-Gaudin; Michel Lonchampt; Marc Bertrand; Jean-Sébastien Saulnier-Blache; Gordon C Tucker; Alex Cordi; Jean A Boutin
Journal:  J Pharmacol Exp Ther       Date:  2008-08-28       Impact factor: 4.030

View more
  6 in total

Review 1.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

Review 2.  Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Authors:  Gabor J Tigyi; Leonard R Johnson; Sue Chin Lee; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Karin Thompson; Alyssa Boler; W Shannon McCool
Journal:  J Lipid Res       Date:  2019-01-28       Impact factor: 5.922

3.  Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.

Authors:  Lauren E Ragle; Dilip J Palanisamy; Margaux J Joe; Rachel S Stein; Derek D Norman; Gabor Tigyi; Daniel L Baker; Abby L Parrill
Journal:  Bioorg Med Chem       Date:  2016-08-04       Impact factor: 3.641

4.  Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitors.

Authors:  Souvik Banerjee; Derek D Norman; Shanshan Deng; Sayo O Fakayode; Sue Chin Lee; Abby L Parrill; Wei Li; Duane D Miller; Gabor J Tigyi
Journal:  Bioorg Chem       Date:  2020-08-26       Impact factor: 5.275

Review 5.  Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.

Authors:  Souvik Banerjee; Suechin Lee; Derek D Norman; Gabor J Tigyi
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

6.  Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors.

Authors:  Christiana Magkrioti; Eleanna Kaffe; Elli-Anna Stylianaki; Camelia Sidahmet; Georgia Melagraki; Antreas Afantitis; Alexios N Matralis; Vassilis Aidinis
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.